Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study.
about
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Clofarabine, high-dose cytarab ...... id leukemia: a phase IB study.
@en
Clofarabine, high-dose cytarab ...... id leukemia: a phase IB study.
@nl
type
label
Clofarabine, high-dose cytarab ...... id leukemia: a phase IB study.
@en
Clofarabine, high-dose cytarab ...... id leukemia: a phase IB study.
@nl
altLabel
Clofarabine, high-dose cytarab ...... oid leukemia: a phase IB study
@en
prefLabel
Clofarabine, high-dose cytarab ...... id leukemia: a phase IB study.
@en
Clofarabine, high-dose cytarab ...... id leukemia: a phase IB study.
@nl
P2093
P2860
P1433
P1476
Clofarabine, high-dose cytarab ...... id leukemia: a phase IB study.
@en
P2093
Benoit Brethon
Brigitte Strahm
C Michel Zwaan
Claudia Rossig
Dana A Chitu
Dirk Reinhardt
Eveline S J M de Bont
Gertjan J L Kaspers
Guy Leverger
Inge M van der Sluis
P2860
P304
P356
10.3324/HAEMATOL.2017.187153
P407
P577
2018-05-17T00:00:00Z